Celsion Corp
Pagina dedicata companiei Celsion Corp listata cu simbolul US.CLSN
Descriere companie[edit | ]
Celsion Corporation (Celsion) (celsion.com) is a clinical stage biotechnology company. The Company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer and ThermoDox, a heat-activated liposomal encapsulation of doxorubicin for several cancer indications. Its GEN-1, an IL-12 DNA plasmid vector formed into nanoparticles with a lipopolymeric delivery system, is the product candidate designed via the TheraPlas platform technology. Its Lysolipid Thermally Sensitive Liposomes (LTSL) technology is a heat-sensitive liposomal formulation that targets disease with therapeutics in the presence of mild heat. Its TheraSilence technology delivers synthetically generated inhibitory RNA (RNAi) to regulate protein expression in target cells.
Grafic actiuni companie[edit | ]